The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of tumor mutation burden (TMB) in tumor (tDNA) and plasma cell free DNA (cfDNA) in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with a combination of cetuximab and nivolumab (C+N).
 
Christine H. Chung
Consulting or Advisory Role - Brooklyn ImmunoTherapeutics; Exelixis; Fulgent Pharma; Genmab; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Regeneron (Inst)
 
Graydon Moorhead
No Relationships to Disclose
 
Nicholas Haradhvala
Consulting or Advisory Role - MorphoSys
 
Laxmi Parida
No Relationships to Disclose
 
Jiannong Li
No Relationships to Disclose
 
Robbert Slebos
Consulting or Advisory Role - Brooklyn ImmunoTherapeutics (I); Exelixis (I); Fulgent Pharma (I); Genmab (I); Merck (I)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Iovance Biotherapeutics (Inst); Lilly O. (Inst); Merck (Inst); Regeneron (Inst)
 
Xiaofei Song
No Relationships to Disclose
 
Ritu Chaudhary
No Relationships to Disclose
 
Maria Poole
No Relationships to Disclose
 
Robin Park
No Relationships to Disclose
 
Kedar Kirtane
Stock and Other Ownership Interests - Agenus; Immunomedics; Macrogenics; Myovant Sciences; Oncternal Therapeutics; Seagen; Veru
Consulting or Advisory Role - MyCareGorithm
 
Conor Ernst Steuer
Honoraria - Merck
Consulting or Advisory Role - Abbvie; ARMO BioSciences; BerGenBio; Caris Life Sciences; Lilly; Mirati Therapeutics; Sanofi/Regeneron
Research Funding - Daiichi Sankyo; Infinity Pharmaceuticals; Seagen; Vaccinex
 
Nabil F. Saba
Honoraria - American Journal OF Managed Care; AstraZeneca; Eisai; EMD Serono; Exelixis; GlaxoSmithKline; Inovio Pharmaceuticals; Merck; Novartis; vaccinex
Research Funding - Bristol-Myers Squibb; Exelixis
Patents, Royalties, Other Intellectual Property - Springer textbook Royalty; Uptodate chapter writing and editing
Travel, Accommodations, Expenses - Merck
 
Priyanka Bhateja
No Relationships to Disclose
 
James William Rocco
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Merck
 
Marcelo Raul Bonomi
Consulting or Advisory Role - Merck
Research Funding - Regeneron (Inst)
 
Brian Danysh
No Relationships to Disclose
 
Gad Getz
Stock and Other Ownership Interests - Scorpion Therapeutics
Honoraria - MD Anderson Cancer Center; Society for Neuro-Oncology; Society of Tumor Oncology
Consulting or Advisory Role - Scorpion Therapeutics
Research Funding - IBM (Inst); Leidos Biomedical Research/NCI (Inst); Pharmacyclics (Inst)
Patents, Royalties, Other Intellectual Property - Patent related to MSIdetect (Inst); Patent related to MSIdetect (Inst); Patents related to bioinformatic tools (Inst); Royalties from licensing tools
 
Aik-choon Tan
No Relationships to Disclose